| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 564* | 2021 |
| Comparison of everolimus-and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds S Puricel, D Arroyo, N Corpataux, G Baeriswyl, S Lehmann, Z Kallinikou, ... Journal of the American College of Cardiology 65 (8), 791-801, 2015 | 251 | 2015 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 104 | 2022 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 43 | 2021 |
| Etomidate for critically ill patients. Con: do you really want to weaken the frail? B De la Grandville, D Arroyo, B Walder European Journal of Anaesthesiology| EJA 29 (11), 511-514, 2012 | 35 | 2012 |
| Comparison of everolimus-and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial D Arroyo, G Gendre, S Schukraft, Z Kallinikou, O Müller, G Baeriswyl, ... International journal of cardiology 243, 121-125, 2017 | 34 | 2017 |
| Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT) X Rossello, S Raposeiras-Roubin, R Latini, A Dominguez-Rodriguez, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (3), 291-301, 2022 | 30 | 2022 |
| Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper P Abraham, DA Arroyo, R Giraud, H Bounameaux, K Bendjelid Open Heart 5 (1), e000735, 2018 | 22 | 2018 |
| Comparison of endothelium-dependent and-independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting … S Puricel, Z Kallinikou, J Espinola, D Arroyo, JJ Goy, JC Stauffer, ... International journal of cardiology 202, 525-531, 2016 | 18 | 2016 |
| Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial D Arroyo, M Togni, S Puricel, B Gerard, L Sonja, N Corpataux, ... Trials 15, 1-6, 2014 | 18 | 2014 |
| Impact of epinephrine and norepinephrine on two dynamic indices in a porcine hemorrhagic shock model R Giraud, N Siegenthaler, D Arroyo, K Bendjelid Journal of Trauma and Acute Care Surgery 77 (4), 564-569, 2014 | 16 | 2014 |
| Ten-year clinical follow-up after sirolimus-eluting stent implantation N Palhais, D Arroyo, S Lehmann, M Togni, U Kaufmann, SG Puricel, ... American Heart Journal 167 (6), 893-899, 2014 | 14 | 2014 |
| Organization of intensive cardiac care units in Europe: Results of a multinational survey MJ Claeys, F Roubille, G Casella, R Zukermann, N Nikolaou, L De Luca, ... European Heart Journal: Acute Cardiovascular Care 9 (8), 993-1001, 2020 | 12 | 2020 |
| Long-Term Comparison of Everolimus-Eluting and Biolimus-Eluting Stents in All-Comer Patients SG Puricel, M Oberhänsli, P Guntern, S Lehmann, JJ Goy, DA Arroyo, ... EuroIntervention 8, 336-344, 2013 | 11 | 2013 |
| Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular … S Schukraft, D Arroyo, M Togni, JJ Goy, P Wenaweser, M Stadelmann, ... Catheterization and Cardiovascular Interventions 99 (3), 523-532, 2022 | 9 | 2022 |
| Impact of intravascular thrombosis on failure of radial arterial catheters in critically ill patients: a nested case-control study Y Fleury, D Arroyo, C Couchepin, H Robert-Ebadi, M Righini, JA Lobrinus, ... Intensive care medicine 44, 553-563, 2018 | 9 | 2018 |
| Suspected arterial vasospasm in femoro-femoral venoarterial extracorporeal life support D Arroyo, K Bendjelid, H Robert-Ebadi, F Rigamonti, N Siegenthaler, ... ASAIO Journal 63 (3), e35-e38, 2017 | 9 | 2017 |
| Heart rate never lies: interventional cardiologist and Braude's quote revised S Cook, JC Stauffer, JJ Goy, D Graf, S Puricel, A Frobert, O Muller, ... Open Heart 3 (1), e000373, 2016 | 8 | 2016 |
| Safety and efficacy of 48 mm Xience Xpedition everolimus‐eluting stent for the treatment of long coronary lesions A Gautier, T Hovasse, D Arroyo, T Unterseeh, P Garot, S Champagne, ... Catheterization and Cardiovascular Interventions 100 (2), 179-187, 2022 | 7 | 2022 |
| Ischemic and bleeding outcomes according to the academic research consortium high bleeding risk criteria in all comers treated by percutaneous coronary interventions D Doomun, I Doomun, S Schukraft, D Arroyo, S Cook, T Huwyler, ... Frontiers in Cardiovascular Medicine 8, 620354, 2021 | 7 | 2021 |
